Long-Acting Glucagon-Like Peptide-1 Receptor Agonist-Induced Rheumatoid Arthritis in a Patient with Type 2 Diabetes Mellitus

Long-Acting Glucagon-Like Peptide-1 Receptor Agonist-Induced Rheumatoid Arthritis in a Patient with Type 2 Diabetes Mellitus

Case Presentation: We report a case of a male patient with rheumatoid arthritis (RA) diagnosed during treatment with a long-acting glucagon-like peptide-1 (GLP-1) receptor agonist (once-weekly dulaglutide injection). At 3 months after dulaglutide initiation, he began experiencing left shoulder pain...

Full description

Bibliographic Details
Main Authors: Koji Kikkawa, Hiroto Hoshi, Atsushi Isoda, Kazuya Okada, Junichi Okada, Takuya Watanabe, Eijiro Yamada, Kihachi Ohshima, Shuichi Okada
Format: Article
Language:English
Published: Karger Publishers 2021-09-01
Series:Dubai Diabetes and Endocrinology Journal
Subjects:
adverse drug reactions
rheumatoid arthritis
glucagon-like peptide-1 receptor agonist
Online Access:https://www.karger.com/Article/FullText/519008

Similar Items

Similar Items